PF-05212384 (PKI-587) for t-AML/MDS or de Novo Relapsed or Refractory Acute Myeloid Leukemia (AML) (LAM-PIK)

Clinical trial NCT02438761 · TERMINATED

Trial details

NCT number: NCT02438761
Sponsor: Institut Curie
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Therapy-related Acute Myeloid Leukemia and Myelodysplastic Syndrome Acute Myeloid Leukemia, in Relapse de Novo Acute Myeloid Leukemia at Diagnostic

Start date: 2015-08-31
Primary completion: 2017-05-10
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.